Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future plans for fundraising through debt or equity in the transcript. The company currently has long-term debt of approximately INR 73 crores, with a normal repayment plan of roughly INR 20 crores per year. Post-demerger, the insoluble sulphur business aims to be self-sustaining and self-generating, implying no need for external cash flows. The management clarified there will be no diversion of funds between the insoluble sulphur division and the new investment company post-demerger. Future capital allocation decisions, including potential divide

Any current/future capex/capital investment/strategic investment?

Currently, no major reinvestment opportunities are planned in the insoluble sulphur division outside of its core operations. The new capacity addition of 5,500 tons of insoluble sulphur in 2022 is operational with current utilization around 75%. No capex is planned beyond this; focus is on utilizing existing capacity. The investment entity post-demerger will continue to undertake new investments, including private investments or incubating new companies, aimed at maximizing shareholder returns. The demerger is intended to unlock value and separate the investment and manufacturing businesses. C

Future growth expectations in sales/revenue/volumes?

Insoluble sulphur division expected to grow around 5% annually with volume growth of 6% to 7%. Aim to increase global market share in insoluble sulphur from 10% to 12%. Sulfuric acid division expected to operate at full capacity; however, it is a low-margin product compared to insoluble sulphur. Volumes of insoluble sulphur have remained roughly flat over recent years with no significant decline. Volume growth expected to improve from Q4 FY24 onwards after some recent degrowth in Q3. New customer onboarding and market expansion efforts ongoing, especially in North America, but alloca

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects long-term growth in the insoluble sulphur division driven by growth in the automotive sector and tire market, targeting a 5-7% volume growth and increasing global market share from 10% to 12%. Sulfuric acid business is expected to operate at full capacity but yields lower margins compared to insoluble sulphur. Short to medium-term challenges include industry oversupply and price pressures, but pricing and volumes are expected to have bottomed out with gradual recovery in Q4 FY24 compared to Q3 FY24. EBITDA margins declined in recent quarters but the company remains co

Current/ Expected Orderbook/ Pending Orders?

The company has onboarded some new customers from their targeted list for the year; new product approvals are in place. They have started dispatching from January onwards to new North American plants, though allocations are still limited compared to expectations. The orderbook shows a start but is smaller than initially hoped. Future business growth depends on increasing customer confidence and allocations rather than product approval. Volume growth is expected to improve in Q4 FY24 compared to Q3 FY24, indicating potentially better order inflow. The sales model is primarily direct s

AG Ventures LtdQ3 FY24Chemicals & Petrochemicals

AG Ventures Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹129.2P/E: 5.7Market Cap: ₹128 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

Order

N/A

Capex

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Insoluble sulphur division expected to grow around 5% annually with volume growth of 6% to 7%.
Aim to increase global market share in insoluble sulphur from 10% to 12%.
Sulfuric acid division expected to operate at full capacity; however, it is a low-margin product compared to insoluble sulphur.
Volumes of insoluble sulphur have remained roughly flat over recent years with no significant decline.
Volume growth expected to improve from Q4 FY24 onwards after some recent degrowth in Q3.
New customer onboarding and market expansion efforts ongoing, especially in North America, but allocations are still limited.
Long-term industry outlook remains promising due to anticipated growth in the automotive sector and increasing demand for premium-grade raw materials.
Prices and margins expected to remain stable in the near term with challenging market conditions due to oversupply.

Margin guidance

Category 3

The company expects long-term growth in the insoluble sulphur division driven by growth in the automotive sector and tire market, targeting a 5-7% volume growth and increasing global market share from 10% to 12%.
Sulfuric acid business is expected to operate at full capacity but yields lower margins compared to insoluble sulphur.
Short to medium-term challenges include industry oversupply and price pressures, but pricing and volumes are expected to have bottomed out with gradual recovery in Q4 FY24 compared to Q3 FY24.
EBITDA margins declined in recent quarters but the company remains confident in sustained earnings growth over the long term due to strong market positioning and cost-saving initiatives like captive solar power.
Post-demerger, focus will be on unlocking shareholder value; reinvestment opportunities are currently limited, with prudent capital allocation aimed at debt repayment, possible dividends or buybacks.
Overall, growth in revenue and profits is expected to align with global automotive demand recovery and tightening supply dynamics.

See what AG Ventures Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or future plans for fundraising through debt or equity in the transcript.
The company currently has long-term debt of approximately INR 73 crores, with a normal repayment plan of roughly INR 20 crores per year.
Post-demerger, the insoluble sulphur business aims to be self-sustaining and self-generating, implying no need for external cash flows.
The management clarified there will be no diversion of funds between the insoluble sulphur division and the new investment company post-demerger.
Future capital allocation decisions, including potential dividends or debt repayment, will be based on cash flow positions after the demerger.
The investment company might undertake new private investments funded from realizations of existing investments rather than fresh fundraising.

Order book

The company has onboarded some new customers from their targeted list for the year; new product approvals are in place.
They have started dispatching from January onwards to new North American plants, though allocations are still limited compared to expectations.
The orderbook shows a start but is smaller than initially hoped.
Future business growth depends on increasing customer confidence and allocations rather than product approval.
Volume growth is expected to improve in Q4 FY24 compared to Q3 FY24, indicating potentially better order inflow.
The sales model is primarily direct supply to customers' plants.
Overall, the company anticipates continued efforts to grow market share and onboarding new clients as allocations improve.

See what AG Ventures Ltd management said on order book — free account, 30 seconds.

Capex plans

Currently, no major reinvestment opportunities are planned in the insoluble sulphur division outside of its core operations.
The new capacity addition of 5,500 tons of insoluble sulphur in 2022 is operational with current utilization around 75%.
No capex is planned beyond this; focus is on utilizing existing capacity.
The investment entity post-demerger will continue to undertake new investments, including private investments or incubating new companies, aimed at maximizing shareholder returns.
The demerger is intended to unlock value and separate the investment and manufacturing businesses.
Capital allocation decisions, including any dividend or debt repayment plans, will depend on cash flows post-demerger.
No specific timeline on new strategic investments; all calls will be prudent and based on cash flow and business needs.

Track AG Ventures Ltd — get its next earnings analysis in your feed

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAG Ventures Ltd

Rev 4Mar 3

See where AG Ventures Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Compare AG Ventures Ltd against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →